I fully confess I was a skeptic when Samsung unveiled the first Note. And I certainly wasn’t alone among the crowd at the Messe Berlin that...
President Joe Biden’s July 2021 executive order set forth a commitment to reinvigorate U.S. innovation and competitiveness. The administration’s efforts...
At least one model from the University of Washington’s Institute for Health Metrics and Evaluation estimates that at this time, 73 percent of Americans...
Northwestern University synthetic biologists have developed a low-cost, easy-to-use, hand-held device that can let users know — within mere minutes —...
Africa is endowed with very rich biodiversity, among which include pathogens causing many of the infectious diseases afflicting the continent. Sadly, Africa...
Janice Chen, CTO of Mammoth Biosciences, spoke to Inside Precision Medicine at the recent Hello Tomorrow conference in Paris about her inspirations, challenges...
Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s The post Pushing the right buttons for...
Tay-Sachs is a rare and fatal neurodegerative disorder that most commonly affects children. Researchers have developed the first Tay-Sachs treatment to...
Novavax, Inc. (NASDAQ:NVAX) has risen in recent days following its request to the Food and Drug Administration to allow its Covid vaccine to be used in...
James Dahlman and Phil Santangelo are helping to define an evolving era in medicine, one in which messenger ribonucleic acid — mRNA — can be delivered...
(n this eBook, sponsored by Thermo Fisher Scientific, we examine the rising role of genetics in medical diagnostics, including polymerase chain reaction (PCR), genomic sequencing, and...
Researchers at Queen Mary University of London have created a low-cost, portable COVID testing kit intended for use in remote, low-resource regions of the world. They...
AUGUSTA, Ga. (Jan. 31, 2022) – The search to better understand the tremendous range of responses to infection with the COVID-19 virus — from symptom free to...
2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of The post Offshore warning as UK biotech investment...
Can these penny stocks push up next month? The post Best Penny Stocks to Buy Next Month? Check These 3 Out appeared first on Penny Stocks...
2020 was devastating. It was also a year of firsts. Fueled by decades of research and widespread global cooperation, the first mRNA-based vaccines against SARS-CoV-2 were...
Increase in the levels of NETs—neutrophil extracellular traps, web like structures made of DNA and histones that trap pathogens—have been linked to autoimmune diseases. In a...
The creative community has been a ripe target for startups building tools and services to serve their interests and needs as they transition from their traditionally...
Scientists have developed a broadly applicable, multiplexable, and scalable platform for detecting interactions of a range of label-free molecules at the single-molecule scale, in real-time, using...
DNA and mRNA vaccines produce a different kind of immune response than traditional vaccines, allowing researchers to tackle some previously unsolvable problems in medicine.
Researchers have been working to develop approaches to curing Type 1 diabetes by transplanting healthy islet cells into the pancreas. Investigators at Northwestern University have developed a technique to make...
Scripps Research scientists devised an approach to help shortcut a key step in modern vaccine development. The researchers married data from high-resolution cryo-electron microscopy to next-gen...
CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.
Drugging RNA has become a hot biopharma topic in recent years, particularly after the massive successes of the Covid-19 vaccines. But one biotech is aiming to...
Drugging RNA and RNA degradation have become hot biopharma topics in recent years, particularly after the massive successes of the Covid-19 vaccines. But one biotech is...
Speaking with French newspaper Le Figaro, Pfizer Chief Executive Officer Albert Bourla said he believes the world will “return to normal life” sometime during the spring of 2022.
CORVALLIS, Ore. – Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant...
A Pennsylvania CDMO specializing in cell and gene therapy manufacturing is receiving a big influx of cash from a South Korean drugmaker — and it has...
Between 2016 and 2021, over 500 researchers collaborated within the DNAqua-Net international network, funded by the European Union’s European Cooperation in Science and Technology programme (COST),...
Stock market news to know as stocks find footing amidst the current volatility. The post Top Stock Market News For Today January 11, 2021 appeared first...